Four years before Kimberly Gallagher enrolled in Medicaid herself, the public health insurance program’s rules prompted her to make an excruciating choice — to give up guardianship of her son so she could work as his caregiver. Now, another proposed twist in the rules could mean that, even though Missouri pays her to do that…
The last time a Republican-controlled Congress and President Donald Trump moved to slash Medicaid spending, in 2017, a key political force stood in their way: GOP governors. Now, as Congress steamrolls toward passing historic Medicaid cuts of about $1 trillion over 10 years through Trump’s tax and spending legislation, red-state governors are saying little publicly…
Bispecific antibodies are already available for treating multiple myeloma. FDA approval of Regeneron Pharmaceuticals’ new drug, Lynozyfic, comes with dosing flexibility that sets it apart from others in its class. The post FDA Approves Regeneron Multiple Myeloma Drug With Dosing Edge Over J&J and Pfizer Meds appeared first on MedCity News.
Catastrophic healthcare expenditures (CHE) are highly problematic for families are are unequally distributed throughout society. However, how can we quantify the incidence, intensity and inequality of CHE in a society? A paper by Ogwang and Mwabu (2025) provide one methodology by using the Watts poverty measure and adapting it to measure CHE. We first describe…
Nordic Capital acquired a majority stake in health data platform Arcadia. Together, the two aim to accelerate the company’s mission of advancing value-based care through AI and data analytics. Arcadia CEO Michael Meucci views the deal as both a validation of the company’s strategy and part of a broader wave of healthcare investments focused on…
Organon said OG-6219 did not beat a placebo in a mid-stage clinical trial whose main goal was to measure the change in pelvic pain caused by endometriosis. The twice-daily pill came from Organon’s 2021 acquisition of Forendo Pharma. The post Organon Stops Work on Endometriosis Drug After Failure in Phase 2 Test appeared first on…
Anmol Madan is CEO of RadiantGraph. He’s building an end to end solution that goes from data ingestion to applications to consumer connection via text/email and voice in order to let payers quickly roll out patient engagement plans. His idea is that plans/payers don’t need to fix their data, RadiantGraph’s AI can take the messy…
El “One Big Beautiful Bill” del presidente Donald Trump recorta el gasto federal en los mercados de Medicaid y la Ley de Cuidado de Salud a Bajo precio (ACA) en aproximadamente $1.000 millones a lo largo de una década, según la Oficina de Presupuesto del Congreso (CBO), una entidad no partidista. Esto amenaza la salud…
To remain resilient amid the volatility, skilled nursing facilities s need to stay on top of what’s impacting operations and consider strategic opportunities. Here are important trends to watch. The post Industry Pressures and Possibilities: What’s Ahead for Skilled Nursing Facilities appeared first on MedCity News.
By keeping our AI and ML grounded in real-world medicine, we can shape a future where prior authorization works smarter, faster, and better for everyone involved. The post Physician-led AI: Unlocking Clinical Productivity In Prior Authorization appeared first on MedCity News.